Scott A Northrup
Overview
Explore the profile of Scott A Northrup including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
45
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Day G, Bryan M, Northrup S, Lyles D, Westcott M, Stewart 4th J
J Surg Res
. 2019 Aug;
245:127-135.
PMID: 31415934
Background: The purpose of this study was to analyze the oncolytic and immunomodulatory functions of an M protein mutant of vesicular stomatitis virus (M51R VSV) in a murine model of...
2.
Blackham A, Northrup S, Willingham M, Sirintrapun J, Russell G, Lyles D, et al.
J Surg Res
. 2013 Nov;
187(2):412-26.
PMID: 24252853
Background: M protein mutant vesicular stomatitis virus (M51R-VSV) has oncolytic properties against many cancers. However, some cancer cells are resistant to M51R-VSV. Herein, we evaluate the molecular determinants of vesicular...
3.
Randle R, Northrup S, Sirintrapun S, Lyles D, Stewart 4th J
Surgery
. 2013 Aug;
154(6):1323-29.
PMID: 23973113
Background: Therapeutic goals for neuroendocrine tumors (NETs) not amenable to operative cure are limited to relieving symptoms and slowing progression. Many malignancies acquire defective antiviral responses as they undergo unregulated...
4.
Blackham A, Northrup S, Willingham M, DAgostino Jr R, Lyles D, Stewart 4th J
Surgery
. 2012 Oct;
153(3):333-43.
PMID: 23102637
Background: Vesicular stomatitis virus (VSV) is a novel, anti-cancer therapy that targets cancer cells selectively with defective antiviral responses; however, not all malignant cells are sensitive to the oncolytic effects...